Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 27793 | 181 | 51.3 | 95% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MUTANT P53 | Author keyword | 7 | 19% | 19% | 34 |
| 2 | GAIN OF FUNCTION | Author keyword | 3 | 12% | 11% | 20 |
| 3 | CANC THER EUT S | Address | 1 | 100% | 1% | 2 |
| 4 | MOL CHEMOPREVENT GRP | Address | 1 | 20% | 2% | 4 |
| 5 | CENERSEN | Author keyword | 1 | 50% | 1% | 1 |
| 6 | CLOROQUINE | Author keyword | 1 | 50% | 1% | 1 |
| 7 | COMPUTAT SCI INFORMAT PROGRAM | Address | 1 | 50% | 1% | 1 |
| 8 | DERMATOL STEM CELL BIOL | Address | 1 | 50% | 1% | 1 |
| 9 | INTEGRATED GENOM CORE | Address | 1 | 50% | 1% | 1 |
| 10 | METABOL SIGNALING DIS PROGRAM | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MUTANT P53 | 7 | 19% | 19% | 34 | Search MUTANT+P53 | Search MUTANT+P53 |
| 2 | GAIN OF FUNCTION | 3 | 12% | 11% | 20 | Search GAIN+OF+FUNCTION | Search GAIN+OF+FUNCTION |
| 3 | CENERSEN | 1 | 50% | 1% | 1 | Search CENERSEN | Search CENERSEN |
| 4 | CLOROQUINE | 1 | 50% | 1% | 1 | Search CLOROQUINE | Search CLOROQUINE |
| 5 | MST 1 | 1 | 50% | 1% | 1 | Search MST+1 | Search MST+1 |
| 6 | MUTANT P53 GAIN OF FUNCTION | 1 | 50% | 1% | 1 | Search MUTANT+P53+GAIN+OF+FUNCTION | Search MUTANT+P53+GAIN+OF+FUNCTION |
| 7 | MUTANT P53 GENE | 1 | 50% | 1% | 1 | Search MUTANT+P53+GENE | Search MUTANT+P53+GENE |
| 8 | P53SIRNA | 1 | 50% | 1% | 1 | Search P53SIRNA | Search P53SIRNA |
| 9 | ALTERNATIVE READING FRAME ARF | 0 | 33% | 1% | 1 | Search ALTERNATIVE+READING+FRAME+ARF | Search ALTERNATIVE+READING+FRAME+ARF |
| 10 | MATCHED THERAPY | 0 | 33% | 1% | 1 | Search MATCHED+THERAPY | Search MATCHED+THERAPY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | P53 GAIN | 3 | 57% | 2% | 4 |
| 2 | P53 INDEPENDENT APOPTOTIC PATHWAYS | 2 | 38% | 3% | 5 |
| 3 | OF FUNCTION MUTANT | 2 | 67% | 1% | 2 |
| 4 | TUMORIGENESIS IN VIVO | 1 | 50% | 1% | 2 |
| 5 | MUTANT P53 GAIN | 1 | 25% | 2% | 4 |
| 6 | GENE CONTRIBUTES | 1 | 20% | 2% | 4 |
| 7 | P53 BASED CYCLOTHERAPY | 1 | 50% | 1% | 1 |
| 8 | TUMOR MALIGNANCY | 0 | 14% | 2% | 3 |
| 9 | OF FUNCTION PHENOTYPE | 0 | 20% | 1% | 2 |
| 10 | IMPAIRED APOPTOTIC FUNCTION | 0 | 33% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| p53 mutations in cancer | 2013 | 220 | 96 | 28% |
| Mutant p53: one name, many proteins | 2012 | 148 | 194 | 19% |
| p53 and its mutants in tumor cell migration and invasion | 2011 | 153 | 95 | 19% |
| When mutants gain new powers: news from the mutant p53 field | 2009 | 346 | 171 | 14% |
| The rebel angel: mutant p53 as the driving oncogene in breast cancer | 2012 | 50 | 164 | 21% |
| TP53 Mutants in the Tower of Babel of Cancer Progression | 2014 | 3 | 147 | 27% |
| The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer | 2013 | 7 | 101 | 26% |
| Transcription regulation by mutant p53 | 2007 | 89 | 90 | 16% |
| Contribution of p53 to Metastasis | 2014 | 15 | 77 | 10% |
| The paradigm of mutant p53-expressing cancer stem cells and drug resistance | 2014 | 7 | 215 | 15% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CANC THER EUT S | 1 | 100% | 1.1% | 2 |
| 2 | MOL CHEMOPREVENT GRP | 1 | 20% | 2.2% | 4 |
| 3 | COMPUTAT SCI INFORMAT PROGRAM | 1 | 50% | 0.6% | 1 |
| 4 | DERMATOL STEM CELL BIOL | 1 | 50% | 0.6% | 1 |
| 5 | INTEGRATED GENOM CORE | 1 | 50% | 0.6% | 1 |
| 6 | METABOL SIGNALING DIS PROGRAM | 1 | 50% | 0.6% | 1 |
| 7 | ROC | 1 | 20% | 1.7% | 3 |
| 8 | BIOPHYS CHEM MOL ONCOL | 1 | 17% | 1.7% | 3 |
| 9 | TRANSLAT ONCOGEN UNIT | 1 | 13% | 2.2% | 4 |
| 10 | CHIM TECNOL CHIM | 0 | 33% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000287161 | MDM2//MDMX//NUTLIN 3 |
| 2 | 0.0000250314 | P53 GENE//P53 MUTANTS//MUTANT P53 |
| 3 | 0.0000245559 | LI FRAUMENI SYNDROME//LI FRAUMENI//GERMLINE P53 MUTATION |
| 4 | 0.0000225745 | P73//P63//DELTA NP73 |
| 5 | 0.0000115898 | VRK1//VRK2//EXPT THER EUT TRANSLAT ONCOL PROGRAM |
| 6 | 0.0000091773 | SESTRIN 2//TP53INP1//SESTRIN |
| 7 | 0.0000082428 | HIPK2//CACYBP SIP//CACYBP |
| 8 | 0.0000070083 | ATF3//ATF5//ACTIVATING TRANSCRIPTION FACTOR 3 |
| 9 | 0.0000069784 | NF Y//NF YB//CCAAT BOX |
| 10 | 0.0000067014 | MIR 34A//MICRORNA 34A//MIR 34 |